Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytokinetics (CYTK) Cash from Restructuring: 2009-2012

Historic Cash from Restructuring for Cytokinetics (CYTK) over the last 4 years, with Dec 2012 value amounting to -$56,000.

  • Cytokinetics' Cash from Restructuring fell 200.00% to -$636,000 in Q3 2013 from the same period last year, while for Sep 2013 it was $1.3 million, marking a year-over-year decrease of 33.92%. This contributed to the annual value of -$56,000 for FY2012, which is 128.87% down from last year.
  • Cytokinetics' Cash from Restructuring amounted to -$56,000 in FY2012, which was down 128.87% from $194,000 recorded in FY2011.
  • In the past 5 years, Cytokinetics' Cash from Restructuring ranged from a high of $194,000 in FY2011 and a low of -$56,000 during FY2012.
  • Its 3-year average for Cash from Restructuring is $46,257, with a median of $769.99 in 2010.
  • In the last 5 years, Cytokinetics' Cash from Restructuring soared by 25,095.20% in 2011 and then slumped by 128.87% in 2012.
  • Yearly analysis of 4 years shows Cytokinetics' Cash from Restructuring stood at $34,463 in 2009, then slumped by 97.77% to $769.99 in 2010, then spiked by 25,095.20% to $194,000 in 2011, then slumped by 128.87% to -$56,000 in 2012.